Miroslav Vytiska
Miroslav Vytiska publishes mostly in Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging, on topics such as Cardiac Imaging and Diagnostics, Coronary Interventions and Diagnostics and Cardiovascular Function and Risk Factors.
- World rank
- #7,533,580 of 7,710,434 ranked researchers
- Rank in Czechia
- #36,694 of 39,303
- Works
- 45
- Citations
- 17
- Citations per work
- 0.4
What does Miroslav Vytiska research?
Miroslav Vytiska's work is mostly in Medicine (71%), Biochemistry, Genetics and Molecular Biology (3%), Social Sciences (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3271.4%
- Medicine3271.4%
- Everything else1022.6%
- Life Sciences13.0%
- Social Sciences13.0%
- Social Sciences13.0%
- 1Cardiology and Cardiovascular Medicine44% of their works
- 2Surgery14% of their works
- 3Radiology, Nuclear Medicine and Imaging11% of their works
- 4Pulmonary and Respiratory Medicine3% of their works
- 5Cancer Research3% of their works
- 6Education3% of their works
Research topics
- Cardiac Imaging and Diagnostics
- Coronary Interventions and Diagnostics
- Cardiovascular Function and Risk Factors
- Acute Myocardial Infarction Research
- Cardiovascular Health and Disease Prevention
- Blood Pressure and Hypertension Studies
- Heart Failure Treatment and Management
- Cardiovascular Disease and Adiposity
Which keywords describe Miroslav Vytiska's research?
The keywords of their largest research topics: Cardiovascular Disease, Myocardial Infarction, Coronary Artery Disease, Atherosclerosis, Cardiac Imaging, Heart Failure, Myocardial Perfusion and Obesity.
- Perivascular Adipose Tissue
- Diagnosis
- Antihypertensive Drugs
- Endothelial Dysfunction
- Acute Coronary Syndromes
- Chamber Quantification
- Coronary Stents
- Guidelines
- Obesity
- Heart Failure
- Atherosclerosis
- Myocardial Infarction
- Cardiovascular Disease
- Coronary Artery Disease
- Cardiac Imaging
- Myocardial Perfusion
- Cardiovascular Events
- Hypertension
- Myocardial Revascularization
- Echocardiography
- Arterial Stiffness
- ST-Segment Elevation
- Blood Pressure
- Epicardial Fat
- Treatment
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 25 words, with their numbers
- Cardiovascular Disease184 topics
- Myocardial Infarction172 topics
- Coronary Artery Disease152 topics
- Atherosclerosis122 topics
- Cardiac Imaging111 topic
- Heart Failure112 topics
- Myocardial Perfusion111 topic
- Obesity112 topics
- Cardiovascular Events102 topics
- Guidelines102 topics
- Hypertension102 topics
- Coronary Stents81 topic
- Myocardial Revascularization81 topic
- Chamber Quantification71 topic
- Echocardiography71 topic
- Acute Coronary Syndromes61 topic
- Arterial Stiffness61 topic
- Endothelial Dysfunction61 topic
- ST-Segment Elevation61 topic
- Antihypertensive Drugs41 topic
- Blood Pressure41 topic
- Diagnosis41 topic
- Epicardial Fat41 topic
- Perivascular Adipose Tissue41 topic
- Treatment41 topic
Where does Miroslav Vytiska work?
Miroslav Vytiska's main affiliation in the publication record is University Hospital Brno, Czechia.
How many publications and citations does Miroslav Vytiska have?
OpenAlex counts 45 works and 17 citations for Miroslav Vytiska, an h-index of 2, ranking #7,533,580 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Miroslav Vytiska. Posts are plain text and can be reported.